Wolfgang G. Eisert

620 total citations
20 papers, 453 citations indexed

About

Wolfgang G. Eisert is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Molecular Biology. According to data from OpenAlex, Wolfgang G. Eisert has authored 20 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 5 papers in Epidemiology and 4 papers in Molecular Biology. Recurrent topics in Wolfgang G. Eisert's work include Antiplatelet Therapy and Cardiovascular Diseases (8 papers), Acute Ischemic Stroke Management (5 papers) and Atrial Fibrillation Management and Outcomes (3 papers). Wolfgang G. Eisert is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (8 papers), Acute Ischemic Stroke Management (5 papers) and Atrial Fibrillation Management and Outcomes (3 papers). Wolfgang G. Eisert collaborates with scholars based in Germany, United States and Canada. Wolfgang G. Eisert's co-authors include Joanne van Ryn, Joachim Stangier, Andreas Clemens, Norbert Hauel, Wolfgang Wienen, Cam P. VanderMaelen, Hartmut Derendorf, D. Stolke, Volker Seifert and Michael R. Buchanan and has published in prestigious journals such as Neurology, Stroke and International Journal of Molecular Sciences.

In The Last Decade

Wolfgang G. Eisert

19 papers receiving 433 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wolfgang G. Eisert Germany 10 218 115 65 60 59 20 453
Miwa Ito Japan 14 259 1.2× 75 0.7× 51 0.8× 62 1.0× 42 0.7× 46 526
Kouichi Sagara Japan 15 565 2.6× 31 0.3× 113 1.7× 101 1.7× 14 0.2× 37 994
Ann‐Catrine Teger‐Nilsson Sweden 11 110 0.5× 76 0.7× 30 0.5× 114 1.9× 176 3.0× 28 487
Janice Rischke Canada 11 149 0.7× 104 0.9× 35 0.5× 65 1.1× 104 1.8× 16 396
Telly A. Meadows United States 5 318 1.5× 75 0.7× 47 0.7× 50 0.8× 56 0.9× 5 498
Henri Caplain France 12 287 1.3× 244 2.1× 14 0.2× 19 0.3× 86 1.5× 23 619
Stefan Carlsson Sweden 14 401 1.8× 330 2.9× 36 0.6× 14 0.2× 230 3.9× 22 809
Marion Dugdale United States 13 151 0.7× 46 0.4× 63 1.0× 48 0.8× 171 2.9× 25 537
Alexander G. Vandell United States 14 364 1.7× 187 1.6× 50 0.8× 19 0.3× 161 2.7× 23 789
Haidar Maatouk Germany 7 324 1.5× 245 2.1× 24 0.4× 14 0.2× 43 0.7× 8 581

Countries citing papers authored by Wolfgang G. Eisert

Since Specialization
Citations

This map shows the geographic impact of Wolfgang G. Eisert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wolfgang G. Eisert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wolfgang G. Eisert more than expected).

Fields of papers citing papers by Wolfgang G. Eisert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wolfgang G. Eisert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wolfgang G. Eisert. The network helps show where Wolfgang G. Eisert may publish in the future.

Co-authorship network of co-authors of Wolfgang G. Eisert

This figure shows the co-authorship network connecting the top 25 collaborators of Wolfgang G. Eisert. A scholar is included among the top collaborators of Wolfgang G. Eisert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wolfgang G. Eisert. Wolfgang G. Eisert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Serebruany, Victor L., Jean‐François Tanguay, Héctor A. Cabrera-Fuentes, et al.. (2020). Verifying Death Reports in the Platelet Inhibition and Patient Outcomes (PLATO) Trial. American Journal of Therapeutics. 27(6). e563–e572. 8 indexed citations
3.
Huang, David & Wolfgang G. Eisert. (2013). CHANCE Trial. Stroke. 44(12). 3623–3624. 8 indexed citations
4.
Schellinger, Peter D., Philip M. Bath, Kennedy R. Lees, et al.. (2012). Assessment of Additional Endpoints for Trials in Acute Stroke – What, When, Where, in Who?. International Journal of Stroke. 7(3). 227–230. 15 indexed citations
5.
Eisert, Wolfgang G.. (2012). Dipyridamole in Antithrombotic Treatment. Advances in cardiology. 47. 78–86. 15 indexed citations
6.
Worthmann, Hans, Reinhard Dengler, Helmut Schumacher, et al.. (2012). Monocyte Chemotactic Protein-1 as a Potential Biomarker for Early Anti-Thrombotic Therapy after Ischemic Stroke. International Journal of Molecular Sciences. 13(7). 8670–8678. 10 indexed citations
7.
d’Esterre, Christopher D., Kenneth M. Tichauer, Richard I. Aviv, Wolfgang G. Eisert, & Ting‐Yim Lee. (2011). Dipyridamole Treatment Prior to Stroke Onset: Examining Post-stroke Cerebral Circulation and Outcome in Rabbits. Translational Stroke Research. 2(2). 186–194. 2 indexed citations
8.
Zoppo, Gregory J. del, Philip B. Gorelick, & Wolfgang G. Eisert. (2010). Innate inflammation and stroke. 1 indexed citations
9.
Eisert, Wolfgang G., Norbert Hauel, Joachim Stangier, et al.. (2010). Dabigatran: An Oral Novel Potent Reversible Nonpeptide Inhibitor of Thrombin. Arteriosclerosis Thrombosis and Vascular Biology. 30(10). 1885–1889. 169 indexed citations
10.
Eisert, Wolfgang G. & Felix Schlachetzki. (2008). Chapter 10 Vascular endothelium and the blood–brain barrier. Handbook of clinical neurology. 92. 197–214. 5 indexed citations
11.
Derendorf, Hartmut, et al.. (2005). Dipyridamole Bioavailability in Subjects With Reduced Gastric Acidity. The Journal of Clinical Pharmacology. 45(7). 845–850. 58 indexed citations
12.
Lorenz, M., et al.. (2003). Accumulation of radiolabelled platelets and fibrin on the carotid artery of rabbits after angioplasty: effects of heparin and dipyridamole. Thrombosis and Haemostasis. 90(12). 1179–1186. 16 indexed citations
13.
Eisert, Wolfgang G.. (2001). Near-field amplification of antithrombotic effects of dipyridamole through vessel wall cells. Neurology. 57(suppl_2). S20–3. 28 indexed citations
14.
Heckel, Armin, et al.. (1994). 6,6-Disubstituted hex-5-enoic acid derivatives as combined thromboxane A2 receptor antagonists and synthetase inhibitors. Journal of Medicinal Chemistry. 37(1). 26–39. 29 indexed citations
15.
Eisert, Wolfgang G.. (1993). Die Waldheimer Prozesse : der stalinistische Terror 1950 : ein dunkles Kapitel der DDR-Justiz. 2 indexed citations
16.
Weber, Elisabetta, Thomas A. Haas, Thomas Müller, et al.. (1990). Relationship between vessel wall 13-HODE synthesis and vessel wall thrombogenecity following injury: Influence of salicylate and dipyridamole treatment. Thrombosis Research. 57(3). 383–392. 24 indexed citations
18.
Weier, Heinz-Ulrich & Wolfgang G. Eisert. (1986). Two-parameter data-acquisition system for slit-scan chromosome analysis. Review of Scientific Instruments. 57(11). 2902–2902. 1 indexed citations
19.
Eisert, Wolfgang G. & Mortimer L. Mendelsohn. (1984). Biological Dosimetry. 5 indexed citations
20.
Eisert, Wolfgang G., et al.. (1981). Nozzle design for the generation of plane liquid surfaces. Cytometry. 1(4). 249–253. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026